International Journal of Social Science & Economic Research
Submit Paper

Title:
SURVEYING CLINICAL ATTITUDES, PERCEPTIONS, AND THE EFFECT OF CULTURAL BARRIERS TOWARDS THE USAGE OF HUMAN PAPILLOMAVIRUS VACCINES IN DELHI-NCR

Authors:
Armaana Chawla

|| ||

Armaana Chawla
The British School, New Delhi

MLA 8
Chawla, Armaana. "SURVEYING CLINICAL ATTITUDES, PERCEPTIONS, AND THE EFFECT OF CULTURAL BARRIERS TOWARDS THE USAGE OF HUMAN PAPILLOMAVIRUS VACCINES IN DELHI-NCR." Int. j. of Social Science and Economic Research, vol. 4, no. 11, Nov. 2019, pp. 7034-7054, ijsser.org/more2019.php?id=534. Accessed Nov. 2019.
APA
Chawla, A. (2019, November). SURVEYING CLINICAL ATTITUDES, PERCEPTIONS, AND THE EFFECT OF CULTURAL BARRIERS TOWARDS THE USAGE OF HUMAN PAPILLOMAVIRUS VACCINES IN DELHI-NCR. Int. j. of Social Science and Economic Research, 4(11), 7034-7054. Retrieved from ijsser.org/more2019.php?id=534
Chicago
Chawla, Armaana. "SURVEYING CLINICAL ATTITUDES, PERCEPTIONS, AND THE EFFECT OF CULTURAL BARRIERS TOWARDS THE USAGE OF HUMAN PAPILLOMAVIRUS VACCINES IN DELHI-NCR." Int. j. of Social Science and Economic Research 4, no. 11 (November 2019), 7034-7054. Accessed November, 2019. ijsser.org/more2019.php?id=534.

References

[1]. Arbyn M., Xu L., Simoens C., Martin-Hirsch P.P. (May 2018). Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. The Cochrane Database of Systematic Reviews, Accessed on 14th July 2019 https://www.ncbi.nlm.nih.gov/pubmed/29740819
[2]. Arteaga, Arkaitz. (2012). The Shape and Structure of HPV. Accessed on 14th July 2019 http://hpv.emedtv.com/hpv-vaccine/hpv-vaccine-and-pregnancy.html
[3]. Brabin, L., Roberts, S.A., Stretch, R., et al. (2009). A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Accessed on 17th July 2019 https://www.nature.com/articles/6605362
[4]. Briones, R., Nan, X., Waks, L. (2012). When vaccines go viral: an analysis of HPV vaccine. Accessed on 16th July 2019 https://www.tandfonline.com/doi/abs/10.1080/10410236.2011.610258
[5]. Centers for Disease Control Prevention (CDC) (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, Accessed on 13th July 2019 https://www.cdc.gov/mmwr/pdf/wk/mm5920.pdf
[6]. Cutts F.T., Franceschi S., Goldie S., Castellsague X., de Sanjose S., Garnett G., Edmunds W.J., Claeys P., Goldenthal K.L., Harper D.M., Markowitz L. (2007). "Human papillomavirus and HPV vaccines: a review". Bulletin of the World Health Organization, Accessed on 13th July 2019 https://scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862007000900018&lng=en&nrm=iso
[7]. Das, M. (2018). Cervical Cancer Controversy in India. The Lancet. Accessed on 14th July 2019 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30018-4/fulltext
[8]. De Vuyst H, Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. (2009). Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina, and anus: a meta-analysis. International Journal of Cancer, Accessed on 14th July 2019 https://www.ncbi.nlm.nih.gov/pubmed/19115209
[9]. Duval, B., Gilca, V., McNeil, S., Dobson, S. (2007). Vaccination against human papillomavirus: A baseline survey of Canadian clinicians' knowledge, attitudes, and beliefs. Accessed on 15th July 2019 https://doi.org/10.1016/j.vaccine.2007.08.041
[10]. Food and Drug Administration. (2012). New Data Presented on GARDASIL, Merck's Cervical Cancer Vaccine, in Women Through Age 45. Accessed on 13th July 2019https://web.archive.org/web/20071112010855/http://www.merck.com/newsroom/press_releases/product/2007_1105.html
[11]. Guerry, S.L., De Rosa, C.J., Markowitz, L.E., et al. (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Accessed on 15th July 2019 https://www.sciencedirect.com/science/article/pii/S0264410X11000910
[12]. Gabriel T., Denise G. "In Republican Race, a Heated Battle Over the HPV Vaccine. New York Times, 13th September 2011 https://web.archive.org/web/20170307110249/http://www.nytimes.com/2011/09/14/us/politics/republican-candidates-battle-over-hpv-vaccine.html?_r=0
[13]. Glaxo prepares to launch Cervarix after EU okay. Reuters, 24th September 2007 https://www.reuters.com/article/glaxo-cervarix/update-1-glaxo-prepares-to-launch-cervarix-after-eu-okay-idUSL2446805720070924
[14]. Grossman, M. (1972). On the Concept of Health Capital and the Demand for Health. Journal of Political Economy, Accessed on 12th June 2019 https://www.journals.uchicago.edu/doi/10.1086/259880
[15]. HPV Vaccine Update. Your Cancer Today, 30th July 2008 http://www.yourcancertoday.com/news/HPV-update.html
[16]. Irigoyen, Claudia. (2017). The Universal Immunization Programme in India. Centre for Public Impact, Accessed on 17th July 2019 https://www.centreforpublicimpact.org/case-study/universal-immunization-program-india/
[17]. Kahn, J.A., Zimet, G.D., Bernstein, D.I., et al. (2005). Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. Accessed on 16th July 2019
[18]. https://www.sciencedirect.com/science/article/abs/pii/S1054139X05003733
[19]. Keelan, J., Pavri, V., Balakrishnan, R., Wilson, K. (2010). An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs. Accessed on 17th July 2019 https://www.sciencedirect.com/science/article/pii/S0264410X09018635
[20]. Kopf, Dan. (2017). Proof that India's growth mostly benefits India's rich. Quartz, Accessed on 17th July 2019 https://qz.com/india/916236/regional-inequality-is-increasing-in-india/
[21]. Krupp, K., Laura, A.V., Kielmann, K., Doddaiah, N., Mysore, S., Reingold, A.L., Madhivanan, P. (2010). Factors Associated With Intention-to-Recommend Human Papillomavirus Vaccination Among Physicians in Mysore, India. Journal of Adolescent Health, Accessed on 16th July 2019 https://www.sciencedirect.com/science/article/abs/pii/S1054139X09003802
[22]. McNeil C. (2006). Who invented the VLP cervical cancer vaccines?. Journal of the National Cancer Institute, Accessed on 13th July 2019 https://www.ncbi.nlm.nih.gov/pubmed/16595773
[23]. Menon, S. Women's Reproductive Health is the Most Neglected Thing in Our Society. Huffington Post, 14th March 2018 https://www.huffingtonpost.in/india-development-review/women-s-reproductive-health-is-the-most-neglected-thing-in-our-society_a_23385135/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAHRcqX7SHgw1Hkdr9Zl-zldy5IGNrHbclhwi52SryAYcjW9ALhX5MHVFtCNRNBQR7V_pye5L524cuhj7ce2L3pdcOhpvQXOdr1Bf3TovclFCY7YIFcoS9OCBh3xamqFyH-lyJujYVJAExSKQqXefRGYZX8iKO0Itxkq8yH19bV5Z
[24]. Moghtaderi, A., Dor, A. (2016). Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening". National Bureau Economic Research, Accessed on 13th July 2019 https://www.nber.org/papers/w22523.pdf
[25]. Narayanan, N. Efficacy, safety, cost: India's decade-old debate on the cervical cancer vaccine erupts again. Scroll, 17th January 2018 https://scroll.in/pulse/865284/efficacy-safety-cost-indias-decade-old-debate-on-the-cervical-cancer-vaccine-erupts-again
[26]. Pandey D., Vanya V., Bhagat S., Shetty J. (2012). Awareness and Attitude towards Human Papillomavirus (HPV) Vaccine among Medical Students in a Premier Medical School in India. Accessed on 16th July 2019 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040619
[27]. Perkins, R.B., Chigurupati, N.L., Apte, G., Clark J.A., et al. (2016). Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers. Human Vaccines and Immunotherapeutics, Accessed on 17th July 2019 https://www.scopus.com/record/display.uri?eid=2-s2.0-84961211122&origin=inward&txGid=f33d1f34921c9834fa26d0960c121c6d
[28]. Schnatz, P.F., Humphrey, K., O'Sullivan, D.M. (2010). Assessment of the perceptions and administration of the human papillomavirus vaccine. Accessed on 16th July 2019 https://insights.ovid.com/crossref?an=00128360-201004000-00004
[29]. Stanley, Secter, M. Chauvin, S., Selk, A. (2018). HPV vaccination in male physicians: A survey of gynecologists and otolaryngology surgeons' attitudes towards vaccination in themselves and their patients. Accessed on 15th July 2019 https://reader.elsevier.com/reader/sd/pii/S240585211730071X?token=58E7400F89203644B326A837936ED21F14F96AE5E0BD8C1804DAC8FC03645B9C1A1895E11853AD950D2F2F39571261E4
[30]. Tan, S. (2016). India's Inequality in Healthcare: The Caste Divide. Humanitarian Aid Relief Trust. Accessed on 12th July 2019 https://www.hart-uk.org/blog/indias-inequality-in-healthcare-the-caste-divide/
[31]. Thaxton L., Waxman A.G. (2015). Cervical cancer prevention: immunization and screening 2015. The Medical Clinics of North America, Accessed on 14th July 2019 https://www.ncbi.nlm.nih.gov/pubmed/25841595
[32]. World Health Organization. (2017). Human papillomavirus vaccines: WHO position paper, May 2017. Weekly Epidemiological Record, Accessed on 14th July 2019 https://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf;jsessionid=5320F8F83989068A1F5229C1E9F324D0?sequence=1
[33]. Zimet, G.D., Rosberger Z., Fisher W.A., Perez S., Stupiansky, N.W. (2013). Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Accessed on 15th July 2019 http://dx.doi.org/10.1016/j.ypmed.2013.05.013

Abstract:
While there exists a vast expanse of research in the West regarding public opinion and perception of preventative human papillomavirus (HPV) vaccinations, there is a large gap in surveying and present scholarship in two regards - firstly with respect to the attitudes, beliefs, and ideas of clinicians themselves towards the HPV vaccine's administration, and secondly a geographical void where there is an extreme lack of such study in the Indian context. This study involves the construction and administration of a simplified survey among a selected sample of 33 highly qualified doctors in the Delhi-NCR region, to test the perception and attitudes towards the HPV vaccine in India. The survey revealed that 61% of respondents always recommend the HPV vaccine, 15% of respondents would often recommend it, 18% of respondents sometimes recommend it and the remaining 6% rarely recommend it. 97% of the respondents in this study were women. While studying the role of cultural barriers in negatively affecting perceptions towards the vaccine, it was found that 85% believed there to be no presence of said barriers for the same. Ultimately, the research combines secondary research of existing studies in the United States and Europe, and juxtaposes the same with contextual study in a hospital's microenvironment in Delhi-NCR, keeping in mind the limitations of such a study.